Kimberly-Clark has finalized its acquisition of Kenvue, forming a leading global consumer health and wellness company with 10 billion-dollar brands including Huggies and Tylenol. The combined entity aims to leverage Kimberly-Clark's growth engine and expects $2.1 billion in run-rate synergies within four years. This merger positions the company to better meet growing consumer health demands worldwide and drive innovation and value creation. Kimberly-Clark will operate through four regional segments and has integrated Kenvue's board members into its governance structure.
Kimberly-Clark's stock trades at USD 108.38 on Pluang as of Nov 02, 2026 21:21 WIB, showing a modest 0.41% gain in the last day. The company holds a market capitalization of $35.90 billion, reflecting its significant presence in the consumer staples sector. Investors on Pluang typically hold Kimberly-Clark shares for about 96 days, indicating steady interest in the stock.
Kenvue is leaving the S&P 500 due to its acquisition by Kimberly-Clark, which is expected to close soon. Kenvue shareholders will receive $3.50 in cash plus Kimberly-Clark shares for each Kenvue share at closing. Okta will replace Kenvue in the S&P 5...
Jim Cramer recommends investors diversify away from struggling AI stocks and consider consumer staples, which rose 11.4% in October. He highlights Kimberly-Clark, Procter & Gamble, Constellation Brands, and Coca-Cola as attractive picks due to their ...
Kimberly-Clark has completed a $4.9 billion private offering of senior unsecured notes in five tranches with maturities from 2028 to 2036. The proceeds will help fund its planned acquisition of Kenvue Inc. and cover related fees, with any remaining f...
